In a study published in the September issue of the journal Cell Stem Cell, investigators found that the low-oxygen microenvironments that ordinarily deprive and starve other kinds of cells are tolerated by a type of stem cell used as the primary material for bone-marrow transplantation.
These cells, called hematopoietic stem cells, are found in marrow and can replicate quickly. Once transplanted, they eventually develop into blood and other types of cells. Their ability to self-renew before they transform into blood forms the basis of their usefulness for bone-marrow transplants.
“The cells convert glucose, or sugars, into energy rather than using oxygen to release energy,” said Dr. Hesham Sadek, assistant professor of internal medicine at UT Southwestern and senior author of the study “They use glycolysis instead of mitochondrial oxidative phosphorylation to meet their energy demands.”
Dr. Sadek and his team sought to understand how hematopoietic cells regulate their metabolism in spite of their inhospitable environment and found the cells expressed a certain gene in a way that enabled them to function without using oxygen.
Understanding more about the function of stem cells and their ability to self renew might lead to new avenues of encouraging the cells to grow in large numbers outside the body, Dr. Sadek said. For example, a potential bone-marrow donor’s cells could be incubated and grown indefinitely, providing stem cells to be used in multiple transplant therapies.
“There have been few studies of the metabolism of stem cells, and our aim was to find out how stem cells can ‘breathe’ and replicate without an oxygen-rich environment crucial for other kinds of cells,” Dr. Sadek said.
In addition to being successfully used for bone-marrow transplantation for years, bone-marrow cells are used in hundreds of studies for heart regeneration, he said.
“The findings of this paper highlight important characteristics of bone-marrow stem cells that make them more likely to survive in the low-oxygen environments present, for example, after a heart attack,” Dr. Sadek said. “These findings may also be exploited to enrich bone-marrow stem and progenitor cells by selecting cells based on their metabolic properties.”
Other UT Southwestern researchers who contributed to the study include lead authors Dr. Tugba Simsek, research assistant, and Fatih Kocabas, student research assistant; Dr. Junke Zheng; postdoctoral researcher; Dr. Ralph DeBerardinis, assistant professor of pediatrics; Ahmed Mahmoud, student research assistant; Dr. Eric Olson, chairman of molecular biology; Dr. Jay Schneider, assistant professor of internal medicine; and Dr. Chengcheng Zhang, assistant professor of physiology and developmental biology.
The research was supported by the American Heart Association, the Donald W. Reynolds Foundation and the Welch Foundation.
Visit http://www.utsouthwestern.org/transplants to learn more about UT Southwestern’s clinical services in transplants, including bone marrow